Europe responding to gene therapy challenge, but picture remains fragmented

20 May 2019 - Germany, Italy and England using outcomes-based deals. ...

Read more →

ICER plans cloud-based tools to accelerate the use of value assessments in the US health care system

20 May 2019 - With a late 2019 launch target, ICER’s Evidence Compendium and Interactive Modeler will enable decision-makers within payers, ...

Read more →

Health Technology Assessment Consumer Consultative Committee March 2019 meeting communiqué

20 May 2019 - A communiqué from the March 2019 meeting of the HTA Consumer Consultative Committee has been published. ...

Read more →

NICE recommends Revlimid as multiple myeloma alternative

17 May 2019 - NICE has recommended Revlimid (lenalidomide), a drug that helps to support the immune system to fight ...

Read more →

Health technology assessment challenges in oncology: 20 years of Value in Health

16 May 2019 - Oncology treatments have changed from chemotherapies to targeted therapies and more recently immuno-oncology.  ...

Read more →

Nivolumab and ipilimumab: drug combination has added benefit in advanced renal cell carcinoma

15 May 2019 - There are no serious disadvantages in terms of overall survival. ...

Read more →

NICE recommends first ever treatment for children with rare muscle wasting condition

15 May 2019 - Children with the rare genetic disorder spinal muscular atrophy can now be treated with nusinersen after NICE ...

Read more →

Analysis of sponsor hearings on PBAC decision making

14 May 2019 - Original research conducted by Melinda Flowers, Sean Lybrand and myself has been published on-line in the ...

Read more →

Congress should revive the Office of Technology Assessment

13 May 2019 - In recent decades, the U.S. economy and society have been propelled forward by a boom in science ...

Read more →

HTA frameworks for RA therapies need improvement, researchers say

13 May 2019 - Cost-effectiveness models for the treatment of rheumatoid arthritis first emerged in the early 2000s when highly effective ...

Read more →

New cancer drugs approved for NHS use in Scotland

13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...

Read more →

SMC - May 2019 decisions

13 May 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

What do transformational shifts mean in terms of ultimate outcomes and ‘value’ of medicines?

9 May 2019 - Emerging ‘one-time’ curative therapies create important new options for patients living with difficult and incurable health ...

Read more →

Institute for Clinical and Economic Review's evidence report finds esketamine may benefit patients with treatment-resistant depression but exceeds cost-effectiveness thresholds

9 May 2019 - Midwest CEPAC to vote on overall value of esketamine during 23 May public meeting. ...

Read more →

Lower price for MS drug paves the way for positive recommendation from NICE

9 May 2019 - A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults ...

Read more →